Predictive clinicopathologic factors for limited response of T3 rectal cancer to combined modality therapy

被引:0
作者
Anne Y. Lin
W. Douglas Wong
Jinru Shia
Bruce D. Minsky
Larissa K. Temple
José G. Guillem
Philip B. Paty
Martin R. Weiser
机构
[1] Memorial Sloan-Kettering Cancer Center,Colorectal Service, Department of Surgery
[2] Memorial Sloan-Kettering Cancer Center,Pathology Service
[3] Memorial Sloan-Kettering Cancer Center,Radiation Oncology Service
来源
International Journal of Colorectal Disease | 2008年 / 23卷
关键词
Rectal cancer; Combined modality therapy; Tumor downstaging;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:243 / 249
页数:6
相关论文
共 57 条
[1]  
Moertel CG(1990)Adjuvant therapy for patients with colon and rectal cancer JAMA 264 1444-1450
[2]  
Fleming TR(1990)Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma N Engl J Med 322 352-358
[3]  
Macdonald JS(1995)Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report Ann Intern Med 122 321-326
[4]  
Moertel CG(2004)Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 1731-1740
[5]  
Fleming TR(2005)Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer Ann Surg 241 829-836
[6]  
Macdonald JS(2002)T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival Dis Colon Rectum 45 895-903
[7]  
Sauer R(1985)Preoperative staging of rectal cancer by intrarectal ultrasound Dis Colon Rectum 28 42-46
[8]  
Becker H(2004)Residual mesorectal lymph node involvement following neoadjuvant combined-modality therapy: rationale for radical resection Ann Surg Oncol 11 187-191
[9]  
Hohenberger W(2001)Neoadjuvant therapy for adenocarcinoma of the rectum: tumor response and acute toxicity Dis Colon Rectum 44 513-522
[10]  
Guillem JG(2006)A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieve no downstaging on the basis of preoperative endorectal ultrasonography Ann Surg Oncol 13 1047-1053